Haemonetics market cap HAE
Share price times shares outstanding: what the whole company sells for, since 2010.
- Today, Nov 2, 2026
- $5.5B
- Highest close in our data
- $7.1B
- Feb 2021
Haemonetics is worth $5.5B at the close on Nov 2, 2026, at $120.14 a share.
That is up 71% over the last year and up 44% over five years.
Its highest close in our data was $7.1B in Feb 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $5.5B | $2.5B | $5.5B | +45% |
| 2025 | $3.8B | $2.3B | $4B | −4% |
| 2024 | $3.9B | $3.7B | $4.9B | −10% |
| 2023 | $4.3B | $3.7B | $4.7B | +9% |
| 2022 | $4B | $2.3B | $4.4B | +47% |
| 2021 | $2.7B | $2.6B | $7.1B | −55% |
| 2020 | $6B | $4B | $6.1B | +3% |
| 2019 | $5.9B | $4.2B | $7B | +19% |
| 2018 | $4.9B | $3.3B | $5.9B | +61% |
| 2017 | $3.1B | $2B | $3.1B | +48% |
| 2016 | $2.1B | $1.3B | $2.1B | +27% |
| 2015 | $1.6B | $1.6B | $2.3B | −17% |
| 2014 | $2B | $1.6B | $2.2B | −11% |
| 2013 | $2.2B | $2B | $2.3B | +8% |
| 2012 | $2.1B | $1.5B | $2.1B | +35% |
| 2011 | $1.5B | $1.4B | $1.8B | −2% |
| 2010 | $1.6B | $1.3B | $1.6B | n/a |
Against its peers
Companies in Medical - Instruments & Supplies nearest Haemonetics' size, closest first, today.
| Company | Market cap |
|---|---|
| HAEHaemonetics | $5.5B |
| MMSIMerit Medical Systems | $5.1B |
| VNTVontier | $5B |
| BMIBadger Meter | $4.5B |
| MSAMSA Safety | $7.2B |
| ICUIICU Medical | $4.1B |
| NVSTEnvista | $4B |
| ATRCAtriCure | $3B |
| WRBYWarby Parker | $2.9B |
| PODDInsulet | $10.7B |
| GMEDGlobus Medical | $10.7B |
| Peer median | $4.7B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Haemonetics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.